A PHASE I STUDY TO EVALUATE THE PHARMACOKINETICS, SAFETY AND ANTIVIRAL EFFECTS OF CONCURRENT ADMINISTRATION OF ZIDOVUDINE (AZT) AND 2'3'-DIDEOXYINOSINE (DDI) IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV):